Taiko Pharmaceutical Co Ltd
TSE:4574

Watchlist Manager
Taiko Pharmaceutical Co Ltd Logo
Taiko Pharmaceutical Co Ltd
TSE:4574
Watchlist
Price: 298 JPY -1.65%
Market Cap: 15.1B JPY

Wall Street
Price Targets

Price Targets Summary
Taiko Pharmaceutical Co Ltd

There are no price targets for Taiko Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Taiko Pharmaceutical Co Ltd Competitors:
Price Targets
1066
Shandong Weigao Group Medical Polymer Co Ltd
40% Upside
300595
Autek China Inc
21% Upside
301122
Caina Technology Co Ltd
6% Upside
HAE
Haemonetics Corp
16% Upside
7780
Menicon Co Ltd
5% Downside
6491
Pegavision Corp
25% Upside

Revenue
Forecast

Revenue Estimate
Taiko Pharmaceutical Co Ltd

For the last 3 years the compound annual growth rate for Taiko Pharmaceutical Co Ltd's revenue is -18%. The projected CAGR for the next 3 years is 5%.

-18%
Past Growth
5%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Taiko Pharmaceutical Co Ltd

Operating Income forecast
is not available for
Taiko Pharmaceutical Co Ltd

Net Income
Forecast

Net Income Estimate
Taiko Pharmaceutical Co Ltd

The compound annual growth rate of Taiko Pharmaceutical Co Ltd's net income for the next 3 years is -26%.

N/A
Past Growth
-26%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Taiko Pharmaceutical Co Ltd's stock price target?
Not Available

Taiko Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Taiko Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
5%

For the last 3 years the compound annual growth rate for Taiko Pharmaceutical Co Ltd's revenue is -18%. The projected CAGR for the next 3 years is 5%.

What is Taiko Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
-26%

The compound annual growth rate of Taiko Pharmaceutical Co Ltd's net income for the next 3 years is -26%.

Back to Top